Clinical Trials Directory

Trials / Unknown

UnknownNCT04078828

PR in Endoscopic LAR for Rectal Cancer

Pelvic Floor Reconstruction (PR) in Endoscopic Low Anterior Resection for Rectal Cancer

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Southwest Hospital, China · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The anastomotic leakage remains the major early complication after laparoscopic anterior resection(LAR) for medium \& low rectal cancer. Pelvic floor reconstruction (PR) is a key step in various standard resections for open radical rectal cancer surgery, which was considered to be helpful for decreasing the rate of leakage. However, PR in endoscopic LAR surgery is not routine practice and remains controversial. The purpose of this study is to evaluate the efficacy of PR during LAR for mid/low rectal carcinoma, especially in preventing anastomotic leakage.

Detailed description

Eligible patients with rectal cancer will be randomly assigned to group with pelvic floor reconstruction(PR) versus group without pelvic floor reconstruction(NPR). We want to investigate the rate of anastomotic leakage and re-operation between the two groups, some other relevant outcomes will be concerned all the same.

Conditions

Interventions

TypeNameDescription
PROCEDUREPelvic floor ReconstructionPelvic floor Reconstruction after laparoscopic anterior resection and double-stapling technique anastomosis were finished.

Timeline

Start date
2019-09-01
Primary completion
2020-08-01
Completion
2022-04-01
First posted
2019-09-06
Last updated
2021-11-30

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04078828. Inclusion in this directory is not an endorsement.